Investigating the effect of CDK4/6 and MDM2 inhibition on melanoma

被引：0
|
作者：
Slesur, Lauren [1 ]
Vilgelm, Anna [2 ]
Al-Rohil, Rami [1 ]
Richmond, Ann [2 ]
机构：
[1] Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA
[2] Tennessee Valley Healthcare Syst, Dept Vet Affairs, Nashville, TN USA
来源：
MOLECULAR CANCER THERAPEUTICS | 2018年 / 17卷 / 01期
关键词：
D O I：
10.1158/1535-7163.TARG-17-B166
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B166
引用
收藏
页数：2
相关论文
共 50 条
  • [1] MDM2 antagonism overcomes resistance to CDK4/6 inhibition in melanoma
    Vilgelm, Anna E.
    Saleh, Nabil
    Riemenschneider, Kelsie
    Slesur, Lauren
    Chen, Sheau-Chian
    Ayers, Gregory D.
    Kauffman, Rondi M.
    Kelley, Mark C.
    Johnson, Douglas B.
    Richmond, Ann
    CANCER RESEARCH, 2018, 78 (13)
  • [2] Amplification of CDK4 and MDM2 in malignant melanoma
    Muthusamy, V
    Hobbs, C
    Nogueira, C
    Cordon-Cardo, C
    McKee, PH
    Chin, L
    Bosenberg, MW
    GENES CHROMOSOMES & CANCER, 2006, 45 (05): : 447 - 454
  • [3] The Utility of MDM2 and CDK4 Immunohistochemistry and MDM2 FISH in Craniofacial Osteosarcoma
    Limbach, Abberly Lott
    Lingen, Mark W.
    McElherne, James
    Mashek, Heather
    Fitzpatrick, Carrie
    Hyjek, Elizabeth
    Mostofi, Reza
    Cipriani, Nicole A.
    HEAD & NECK PATHOLOGY, 2020, 14 (04): : 889 - 898
  • [4] The Utility of MDM2 and CDK4 Immunohistochemistry and MDM2 FISH in Craniofacial Osteosarcoma
    Abberly Lott Limbach
    Mark W. Lingen
    James McElherne
    Heather Mashek
    Carrie Fitzpatrick
    Elizabeth Hyjek
    Reza Mostofi
    Nicole A. Cipriani
    Head and Neck Pathology, 2020, 14 : 889 - 898
  • [5] MDM2 and CDK4 as a therapeutic target in sarcomas
    Blay, J.
    Le Cesne, A.
    Cassier, P.
    Ray-Coquard, I.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S70 - S70
  • [6] MDM2 and CDK4 expression in periosteat osteosarcoma
    Righi, Alberto
    Gambarotti, Marco
    Benini, Stefania
    Gamberi, Gabriella
    Cocchi, Stefania
    Picci, Piero
    Bertoni, Franco
    HUMAN PATHOLOGY, 2015, 46 (04) : 549 - 553
  • [7] CDK4 inhibition diminishes p53 activation by MDM2 antagonists
    Sriraman, Anusha
    Dickmanns, Antje
    Najafova, Zeynab
    Johnsen, Steven A.
    Dobbelstein, Matthias
    CELL DEATH & DISEASE, 2018, 9
  • [8] CDK4 inhibition diminishes p53 activation by MDM2 antagonists
    Anusha Sriraman
    Antje Dickmanns
    Zeynab Najafova
    Steven A. Johnsen
    Matthias Dobbelstein
    Cell Death & Disease, 9
  • [9] MDM2 antagonists overcome intrinsic resistance to CDK4/6 inhibition by inducing p21
    Vilgelm, Anna E.
    Saleh, Nabil
    Shattuck-Brandt, Rebecca
    Riemenschneider, Kelsie
    Slesur, Lauren
    Chen, Sheau-Chiann
    Johnson, C. Andrew
    Yang, Jinming
    Blevins, Ashlyn
    Yan, Chi
    Johnson, Douglas B.
    Al-Rohil, Rami N.
    Halilovic, Ensar
    Kauffmann, Rondi M.
    Kelley, Mark
    Ayers, Gregory D.
    Richmond, Ann
    SCIENCE TRANSLATIONAL MEDICINE, 2019, 11 (505)
  • [10] MDM2 and CDK4 Coexpression Is Uncommon in Sarcomatoid Carcinomas
    Sukeda, A.
    Yoshida, A.
    Yoshida, M.
    Tsuta, K.
    Kushima, R.
    Tsuda, H.
    MODERN PATHOLOGY, 2013, 26 : 21A - 22A
12345